Dr. Jacob Y. Shin, MD

Dr. Shin practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Shin's NPI, 1003221763, was assigned on June 21, 2014. Dr. Shin graduated from Boston University School Of Medicine in 2014. Dr. Shin holds New York license 299188.

Dr. Shin's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Shin's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Monmouth. Dmand AI also links Dr. Shin to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shin practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Shin's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Shin is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Shin's licenses on file in 6 states: New York, Florida, New Jersey, California, Illinois and Massachusetts.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, lung cancer radiation and lymphoma radiation among the conditions Dr. Shin treats.

CMS data shows 3,896 Medicare services from Dr. Shin across 19 procedure codes in 2024, for 843 Medicare patients. Medicare paid $267,890 for them.

CMS counts 843 Medicare patients who saw Dr. Shin in 2024. The largest group is 65 to 74, with 413 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shin's median patient age at 73, with 47% women.

In 2024, Dr. Shin wrote 97 Medicare Part D claims for 65 patients. 82% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $725 in total drug cost. In 2023, CMS named 112 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Shin for performance year 2024, reported as part of a group. Dr. Shin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shin as offering telehealth.

Dmand AI links 42 papers to Dr. Shin, published from 2007 to 2025. 2016 was the busiest year, with 4. The most frequent topics are SEER Program, Brain Neoplasms and Lymph Node Excision. Dr. Shin has published most often in Br J Cancer. Dr. Shin's most frequent co-authors are Aidnag Z. Diaz, MD, Jonathan Samuel Berek, MD and Daniel R. Gomez, MD.

Dmand AI links Dr. Shin to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 4 general payments to Dr. Shin from 2 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. Varian Medical Systems, Inc. paid the most, $48.

Dr. Shin graduated from Boston University School Of Medicine in 2014.

Dr. Shin is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.